J. Catama

发表

Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022

M. Ospina-Martínez, M. Mercado-Reyes, J. Malagón-Rojas, 2022, Vaccines.

Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021

M. Herrera, K. Laiton-Donato, C. Franco-Muñoz, 2022, medRxiv.

Seroprevalence of SARS-CoV-2 Antibodies in Children and Adolescents: Results From a Population-Based Survey in 10 Colombian Cities

M. Mercado-Reyes, Marcela Daza, M. Galindo, 2022, Global pediatric health.

Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia

K. Laiton-Donato, C. Franco-Muñoz, D. A. Álvarez-Díaz, 2022, Vaccines.